ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2914

Modifiable and Non-Modifiable Correlates of Satisfaction with Care in Systemic Lupus Erythematosus

Syed Alam1, Nisarg Gandhi2, Alana Nevares1, Ailda Nika2, Winston Sequeira2 and Meenakshi Jolly3, 1Internal Medicine, Cook County Hospital, Chicago, IL, 2Rheumatology, Rush University Medical Center, Chicago, IL, 3Department of Medicine, Section of Rheumatology, Rush University Medical Center, Chicago, IL

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Corticosteroids and systemic lupus erythematosus (SLE), Disease Activity, Health Care

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Systemic Lupus Erythematosus - Clinical Aspects and Treatment Poster Session III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Systemic Lupus Erythematosus (SLE) a chronic disease, predominantly of young women, which may involve various organs, and is marked by periods of disease flares, activity and damage. It may interfere with training, work, social life, and performance of important roles in life. Its treatment may involve use of corticosteroids and immunosuppressive medications which may cause side effects. SLE can adversely impact various aspects of one’s life and may significantly impair quality of life of patients and their loved ones.  With the aim of improving patient care, we sought to determine significant modifiable and non-modifiable correlates of satisfaction with care (SC) in SLE.

Methods: Fifty consenting SLE patients fulfilling ACR classification criteria were given self-administered surveys (FACIT-Fatigue, Self-reported Fibromyalgia Tender Point, Pain, Insomnia Severity Index for Sleep, Perceived Stress Scale-4, Patient Health Questionnaire-9 for depression, LupusPRO) at routine care visits.  Disease activity and damage were assessed using SELENA-SLEDAI (SS) and SLICC/ACR (SDI). Non-modifiable variables of interest were age, gender, education, marital status, disease duration, number of ACR criteria, damage, lupus nephritis (LN) diagnosis and fibromyalgia (FM) diagnosis. Modifiable variables of interest included disease activity, current use and current dose of corticosteroids, specific SLE medications, self-reported FM tender point count, pain, insomnia, fatigue, depression and stress. SC was measured using the LupusPRO SC domain items. Univariate and multivariate regression modeling was done, with SC as a dependent variable and with the above variables of interest. P value of ≤0.05 on two tailed test was significant. Bonferroni correction was used for the final model, and a p ≤0.006 was significant on two tailed test.

Results: Mean (SD) age was 41.4+13 years, 90% participants were women. Ethnic background was as follows: 56% Blacks, 24% Whites, 10% Asians and 10% Others. Median (IQR) values of Physician Global Assessment (PGA), total SS, and SDI were 0.5 (0.8), 4.0(6.0) and 1.0(1.0), respectively.  Age, education, disease duration, damage, FM diagnosis and LN diagnosis were the non-modifiable, while disease activity, current corticosteroid dose and fatigue were the modifiable correlates of SC (Table 1). Greater disease activity, disease duration and FM were associated with better SC. Together these 8 variables accounted for 51% variance in SC. After Bonferroni correction, age, education and FM were not significant in the model, but rest remained significant.

Conclusion: Fatigue and current daily dose of steroids are significant and modifiable correlates of satisfaction with care in SLE, even after adjusting for FM.  We suggest proactive assessment and interventions targeted towards addressing fatigue and steroid dose reduction at each visit for SLE patients.

Table 1: Multivariate Model for Satisfaction with Care
Variable Standardized Beta 95% CI

P value 

*significant after Bonferonni correction for multiple comparisons

Non-modifiable
   Age -0.32 -1.28, -0.10 0.024
   Education -0.39 -23.94, -3.53 0.010
   Disease duration 0.38 0.44, 2.60 0.007
   Lupus nephritis -0.63 -53.25, -17.50 0.0001*
   Fibromyalgia 0.37 3.85, 50.46 0.024
Modifiable
   Disease activity 0.55 1.32, 4.89 0.001*
   Fatigue -0.45 -1.73, -0.40 0.003*
   Daily prednisone dose -0.41 -1.17, -0.21 0.006*


Disclosure: S. Alam, None; N. Gandhi, None; A. Nevares, None; A. Nika, None; W. Sequeira, None; M. Jolly, Pfizer Inc, 7.

To cite this abstract in AMA style:

Alam S, Gandhi N, Nevares A, Nika A, Sequeira W, Jolly M. Modifiable and Non-Modifiable Correlates of Satisfaction with Care in Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/modifiable-and-non-modifiable-correlates-of-satisfaction-with-care-in-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/modifiable-and-non-modifiable-correlates-of-satisfaction-with-care-in-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology